Assurant® Cobalt Iliac Stent Features Novel Alloy and Modular Design; Company’s Peripheral Portfolio Augmented with Balloon-Expandable Option
Medtronic
FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation
Medtronic has announced that the FDA Circulatory Systems Devices advisory panel has voted against the company’s Phased RF Ablation System,
St. Jude 3rd quarter earnings call: Medtronic sparks Starks criticism
St Jude CEO Daniel Starks blasted rival Medtronic in 3rd quarter earnings call.
Medtronic Rises to the Challenge: Tests announced of Drug-Eluting Stent for Erectile Dysfunction
Medtronic, Inc.has announced the initiation of a feasibility study of an interventional treatment for erectile dysfunction that uses a specially-designed drug-eluting stent system.
Medtronic Announces 510(k) Clearance for the Aquamantys®3 System with Combined Hemostatic Sealing and Cutting Functionality
Medtronic, Inc. has announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for its Aquamantys®3 System as well as the new 8.2L Bipolar Sealer with Cutting and 6.0 Bipolar Sealer hand pieces.
Medtronic Announces Results From TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation
First Ever Randomized, Controlled Clinical Trial in Persistent Atrial Fibrillation (AF) Patients
William A. Hawkins Appointed New CEO of Immucor
Former Medtronic CEO Bill Hawkins to be new CEO at blood screening and equipment company Immucor
Medtronic CEO: Medical technology without regard to cost not sustainable
Medtronic CEO Omar Ishrak aired his views at the Cleveland Clinic Medical Innovation Summit
UPDATE: Medtronic adds jobs in Puerto Rico while Smiths Group plans cuts
Medtronic plans to add about 200 workers to its Juncos, Puerto Rico, campus while Smiths Group announces job cuts and plant closures for its detection devices arm.
Medtronic Wins $101 Million Award From NuVasive Over Spinal Device Patents
Medtronic has won a 100M$+ verdict against Nuvasive for patent infringement in the 14th-largest jury award in the U.S. so far in 2011, according to data compiled by Bloomberg News
Spine Surgery Patient Brings Suit Against Medtronic, Inc. (MDT) for “Devastating Side Effects” From off label application of its Infuse Bone Graft Medical Device
Embattled medical device giant Medtronic Inc is feeling the heat again, as reported on www.devicespace.com. This time it is alleged … continue reading “Spine Surgery Patient Brings Suit Against Medtronic, Inc. (MDT) for “Devastating Side Effects” From off label application of its Infuse Bone Graft Medical Device”
Medtronic: More job cuts ahead in 2012
Medtronic has already cut more than 1,400 positions in 2011 and is looking to shed about 2,100 positions overall, according to regulatory documents.
Medtronic’s pain pump recall won’t hurt the bottom line, analysts say
Analysts don’t expect Medtronic’s second Class I recall for its SynchroMed II implantable painkiller pump to put much of a dent in the overall business.
FDA Cites Dangerous Flaw in Medtronic Drug Pump
An implantable drug pump that Medtronic Inc. recalled has a potentially life-threatening design problem, says the U.S. Food and Drug Administration.
Medtronic Announces Launch of ARTISAN™ Space Maintenance System
New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications
The Reality of “Hacking” Medical Devices
It’s possible medical devices face an immediate threat that medical researchers will have to deal with